|
1
|
Clark PA: Puberty: When it comes too soon
guidelines for the evaluation of sexual precocity. J Ky Med Assoc.
96:440–447. 1998.PubMed/NCBI
|
|
2
|
Lv X, Liu F, Shang Y and Chen SZ: Honokiol
exhibits enhanced antitumor effects with chloroquine by inducing
cell death and inhibiting autophagy in human non-small cell lung
cancer cells. Oncol Rep. 34:1289–1300. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhao R, Chen M, Jiang Z, Zhao F, Xi B,
Zhang X, Fu H and Zhou K: Platycodin-D induced autophagy in
non-small cell lung cancer cells via PI3K/Akt/mTOR and MAPK
signaling pathways. J Cancer. 6:623–631. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lu W, Zhang H, Niu Y, Wu Y, Sun W, Li H,
Kong J, Ding K, Shen HM, Wu H, et al: Long non-coding RNA linc00673
regulated non-small cell lung cancer proliferation, migration,
invasion and epithelial mesenchymal transition by sponging
miR-150-5p. Mol Cancer. 16:1182017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Choi JY, Hong WG, Cho JH, Kim EM, Kim J,
Jung CH, Hwang SG, Um HD and Park JK: Podophyllotoxin acetate
triggers anticancer effects against non-small cell lung cancer
cells by promoting cell death via cell cycle arrest, ER stress and
autophagy. Int J Oncol. 47:1257–1265. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Giatromanolaki A, Kalamida D, Sivridis E,
Karagounis IV, Gatter KC, Harris AL and Koukourakis MI: Increased
expression of transcription factor EB (TFEB) is associated with
autophagy, migratory phenotype and poor prognosis in non-small cell
lung cancer. Lung Cancer. 90:98–105. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hwang KE, Kim YS, Jung JW, Kwon SJ, Park
DS, Cha BK, Oh SH, Yoon KH, Jeong ET and Kim HR: Inhibition of
autophagy potentiates pemetrexed and simvastatin-induced apoptotic
cell death in malignant mesothelioma and non-small cell lung cancer
cells. Oncotarget. 6:29482–29496. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Izdebska M, Klimaszewska-Wiśniewska A,
Hałas M, Gagat M and Grzanka A: Green tea extract induces
protective autophagy in A549 non-small lung cancer cell line.
Postepy Hig Med Dosw (Online). 69:1478–1484. 2015.PubMed/NCBI
|
|
9
|
Lee JG, Shin JH, Shim HS, Lee CY, Kim DJ,
Kim YS and Chung KY: Autophagy contributes to the chemo-resistance
of non-small cell lung cancer in hypoxic conditions. Respir Res.
16:1382015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu JT, Li WC, Gao S, Wang F, Li XQ, Yu
HQ, Fan LL, Wei W, Wang H and Sun GP: Autophagy inhibition
overcomes the antagonistic effect between gefitinib and cisplatin
in epidermal growth factor receptor mutant non-small-cell lung
cancer cells. Clin Lung Cancer. 16:e55–e66. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wei J, Ma Z, Li Y, Zhao B, Wang D and Jin
Y and Jin Y: miR-143 inhibits cell proliferation by targeting
autophagy-related 2B in non-small cell lung cancer H1299 cells. Mol
Med Rep. 11:571–576. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu JH, Yang HP, Zhou XD, Wang HJ, Gong L
and Tang CL: Autophagy accompanied with
bisdemethoxycurcumin-induced apoptosis in non-small cell lung
cancer cells. Biomed Environ Sci. 28:105–115. 2015.PubMed/NCBI
|
|
13
|
Zhang L, Dai F, Sheng PL, Chen ZQ, Xu QP
and Guo YQ: Resveratrol analogue 3,4,4′-trihydroxy-trans-stilbene
induces apoptosis and autophagy in human non-small-cell lung cancer
cells in vitro. Acta Pharmacol Sin. 36:1256–1265. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sankar P, Telang AG, Ramya K, Vijayakaran
K, Kesavan M and Sarkar SN: Protective action of curcumin and
nano-curcumin against arsenic-induced genotoxicity in rats in vivo.
Mol Biol Rep. 41:7413–7422. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
De R, Kundu P, Swarnakar S, Ramamurthy T,
Chowdhury A, Nair GB and Mukhopadhyay AK: Antimicrobial activity of
curcumin against Helicobacter pylori isolates from India and during
infections in mice. Antimicrob Agents Chemother. 53:1592–1597.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Soni KB and Kuttan R: Effect of oral
curcumin administration on serum peroxides and cholesterol levels
in human volunteers. Indian J Physiol Pharmacol. 36:273–275.
1992.PubMed/NCBI
|
|
17
|
Betts JW, Sharili AS, La Ragione RM and
Wareham DW: In vitro antibacterial activity of curcumin-polymyxin B
combinations against multidrug-resistant bacteria associated with
traumatic wound infections. J Nat Prod. 79:1702–1706. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhu DJ, Huang YF, Chen XW, Luo ZT, Wang
GX, Liu CC, Zhang WJ and Ouyang MZ: Curcumin partly ameliorates
irinotecan-induced diarrhea and synergistically promotes apoptosis
in colorectal cancer through mediating oxidative stress.
Oncotarget. Jul 14–2016.(Epub ahead of print).
|
|
19
|
Bjelogrlić SK, Srdić T and Radulović S:
Mammalian target of rapamycin is a promising target for novel
therapeutic strategy against cancer. J BUON. 11:267–276.
2006.PubMed/NCBI
|
|
20
|
Micke P, Mattsson JS, Djureinovic D, Nodin
B, Jirström K, Tran L, Jönsson P, Planck M, Botling J and
Brunnström H: The impact of the fourth edition of the WHO
classification of lung tumours on histological classification of
resected pulmonary NSCCs. J Thorac Oncol. 11:862–872. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Laplante M and Sabatini DM: mTOR signaling
in growth control and disease. Cell. 149:274–293. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Efeyan A and Sabatini DM: mTOR and cancer:
Many loops in one pathway. Curr Opin Cell Biol. 22:169–176. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Salmena L, Carracedo A and Pandolfi PP:
Tenets of PTEN tumor suppression. Cell. 133:403–414. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Benjamin D, Colombi M, Moroni C and Hall
MN: Rapamycin passes the torch: A new generation of mTOR
inhibitors. Nat Rev Drug Discov. 10:868–880. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Baehrecke EH: Autophagy: Dual roles in
life and death? Nat Rev Mol Cell Biol. 6:505–510. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shi J, Wang Y, Jia Z, Gao Y, Zhao C and
Yao Y: Curcumin inhibits bladder cancer progression via regulation
of b-catenin expression. Tumour Biol. 39:10104283177025482017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Granados-Castro LF, Rodríguez-Rangel DS,
Fernández-Rojas B, León-Contreras JC, Hernández-Pando R,
Medina-Campos ON, Eugenio-Pérez D, Pinzón E and Pedraza-Chaverri J:
Curcumin prevents paracetamol-induced liver mitochondrial
alterations. J Pharm Pharmacol. 68:245–256. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Trujillo J, Molina-Jijón E, Medina-Campos
ON, Rodríguez-Muñoz R, Reyes JL, Loredo ML, Barrera-Oviedo D,
Pinzón E, Rodríguez-Rangel DS and Pedraza-Chaverri J: Curcumin
prevents cisplatin-induced decrease in the tight and adherens
junctions: Relation to oxidative stress. Food Funct. 7:279–293.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kabeya Y, Mizushima N, Ueno T, Yamamoto A,
Kirisako T, Noda T, Kominami E, Ohsumi Y and Yoshimori T: LC3, a
mammalian homologue of yeast Apg8p, is localized in autophagosome
membranes after processing. EMBO J. 19:5720–5728. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang S, Shu L, Dilling MB, Easton J,
Harwood FC, Ichijo H and Houghton PJ: Sustained activation of the
JNK cascade and rapamycin-induced apoptosis are suppressed by
p53/p21(Cip1). Mol Cell. 11:1491–1501. 2003. View Article : Google Scholar : PubMed/NCBI
|
